FDA Approves Over 40 New Treatment Options in 2019
In a relentless pursuit to improve patient outcomes, research continues to yield new drugs as well as new uses for existing treatments. In 2019, the U.S. Food and Drug Administration (FDA) approved over 40 new treatment options, including 15 novel drugs for different cancer types and blood disorders. Click here for an official list of approvals through the years.
These life-changing advancements are not possible without clinical research trials! More than 400 Illinois CancerCare patients participated in clinical trials in 2019 – with a total of over 3,500 in the last decade. A special Thank You to all of the #ResearchHeros here at Illinois CancerCare, across the nation, and around the world. You are truly making a difference for us all!
To learn more about clinical trials and what opportunities we may have for you, contact our research department at 309.243.3605 or click here.
